Russia has started comparative clinical trials of Mefloquine, Hydroxychloroquine and Kalidavir drugs for coronavirus patients, the Federal Medical-Biological Agency said on Tuesday
MOSCOW (Pakistan Point News / Sputnik - 07th April, 2020) Russia has started comparative clinical trials of Mefloquine, Hydroxychloroquine and Kalidavir drugs for coronavirus patients, the Federal Medical-Biological Agency said on Tuesday.
"Comparative clinical trials of Hydroxychloroquine and Mefloquine, and Russian medication Kalidavir, which will be used ... for treatment of patients with the novel coronavirus infection SARS-CoV-2, have started," the agency said.
The clinical trials will be conducted at the federal medical biophysical center, named after Burnazyan, under written consent of coronavirus patients, the agency added.
